This document is an excerpt from the EUR-Lex website
Document C:2015:152:TOC
Official Journal of the European Union, C 152, 8 May 2015
Official Journal of the European Union, C 152, 8 May 2015
Official Journal of the European Union, C 152, 8 May 2015
|
ISSN 1977-091X |
||
|
Official Journal of the European Union |
C 152 |
|
|
||
|
English edition |
Information and Notices |
Volume 58 |
|
Notice No |
Contents |
page |
|
|
II Information |
|
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
|
European Commission |
|
|
2015/C 152/01 |
Non-opposition to a notified concentration (Case M.7549 — CGG/Wood Mackenzie/JV) ( 1 ) |
1 |
|
2015/C 152/02 |
Non-opposition to a notified concentration (Case M.7276 — GlaxoSmithKline/Novartis vaccines business (excl. influenza)/Novartis consumer health business) ( 1 ) |
1 |
|
|
IV Notices |
|
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
|
European Commission |
|
|
2015/C 152/03 |
2 |
|
|
2015/C 152/04 |
3 |
|
|
2015/C 152/05 |
4 |
|
|
2015/C 152/06 |
Final Report of the Hearing Officer — Munksjö/Ahlstrom (M.6576) |
5 |
|
2015/C 152/07 |
Summary of Commission Decision of 24 May 2013 declaring a concentration compatible with the internal market and the functioning of the EEA Agreement (Case M.6576 — Munksjö/Ahlstrom) (notified under document C(2013) 2966) ( 1 ) |
7 |
|
|
NOTICES FROM MEMBER STATES |
|
|
2015/C 152/08 |
11 |
|
|
V Announcements |
|
|
|
ADMINISTRATIVE PROCEDURES |
|
|
|
European Commission |
|
|
2015/C 152/09 |
12 |
|
|
2015/C 152/10 |
14 |
|
|
|
|
|
(1) Text with EEA relevance |
|
EN |
|